Proctofoam HC, Analpram E (hydrocortisone topical/pramoxine topical) dosing, indications, interactions, adverse effects, and more

Sections

Sections hydrocortisone topical/pramoxine topical
Dosing & Uses
Adverse Effects
Warnings
Pregnancy
Pharmacology
Images
Patient Handout
Formulary

Dosing & Uses

AdultPediatricGeriatric

Dosage Forms & Strengths

hydrocortisone/pramoxine topical

rectal aerosol foam

1%HC/1% pramoxine

cream

0.5%HC/1% pramoxine
1%HC/1% pramoxine
2.5%HC/1% pramoxine

lotion

1%HC/1% pramoxine
2.5%HC/1% pramoxine

Topical Inflammation

Relief of inflammation and pruritus associated with corticosteroid-responsive dermatoses

Apply to affected area q6-8hr depending on severity of condition

Hemorrhoids

Apply rectally q6-8hr

Administration: Using rectal applicator, insert tip into anus and expel measured cream/foam

Other Information

Topically applied corticosteroids can produce systemic effects

Occlusive dressings may be used for psoriasis or recalcitrant conditions if needed

Pramoxine’s unique chemical structure may minimize danger of cross-sensitivity reactions in patients allergic to other local anesthetics

Limit use in children to least amount compatible with an effective therapeutic regimen

Absorption in pediatrics may result in higher blood levels and thus more susceptibility to systemic toxicity

Topical Inflammation

Relief of inflammation and pruritus associated with corticosteroid-responsive dermatoses

Apply to affected area q6-8hr depending on severity of condition

Hemorrhoids

Apply rectally q6-8hr

Administration: Using rectal applicator, insert tip into anus and expel measured cream/foam

Frequency Not Defined

Burning

Itching

Irritation

Dryness

Folliculitis

Hypertrichosis

Acneiform eruptions

Hypopigmentation

Perioral dermatitis

Allergic contact dermatitis

Maceration of the skin

Secondary infection

Skin atrophy

Striae

Miliaria

Contraindications

Hypersensitivity to any components of preparation

Cautions

Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia and glucosuria

Conditions which augment systemic absorption include the application of the more potent steroids, use over large surface areas, prolonged use and the addition of occlusive dressings

Evaluate susceptible patients periodically for evidence of HPA axis suppression by using the urinary free cortisol and ACTH stimulation tests; If HPA axis suppression is noted, withdraw the drug, reduce frequency of application, or substitute a less potent steroid

Contact dermatitis may occur; discontinue use if irritation occurs and treat appropriately

Prolonged use may result in fungal or bacterial superinfection; discontinue if dermatological infection persists despite appropriate antimicrobial therapy

Topical corticosteroids may cause manifestations of Cushing’s syndrome, hyperglycemia, or glycosuria; absorption is increased by use of occlusive dressings, application to denuded skin, application to large surface, or prolonged use

Use caution in the elderly; use smallest possible effective dose for shortest duration

Do not insert any part of aerosol container directly into anus; discontinue if after 2-3 weeks there is no evidence of clinical or proctologic improvement or if condition worsens

Pregnancy & Lactation

Pregnancy Category: C

Lactation: excretion in milk unknown; use with caution

Pregnancy Categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

Mechanism of Action

Hydrocortisone: anti-inflammatory, antipruritic and vasoconstrictive actions; may decrease inflammation by suppressing the migration of polymorphonuclear leukocytes (PMNs) and reversing increased capillary permeability

Pramoxine: surface or local anesthetic

Absorption

Extent determined by many factors including vehicle, integrity of epidermal barrier, use of occlusive dressings

Distribution

Protein bound: Variable

Metabolism

Primarily by liver

Excretion

Primarily by urine

Images

No images available for this drug.

Patient Handout

A Patient Handout is not currently available for this monograph.

Formulary

FormularyPatient Discounts

Adding plans allows you to compare formulary status to other drugs in the same class.

To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.

Create Your List of Plans

Adding plans allows you to:

View the formulary and any restrictions for each plan.
Manage and view all your plans together – even plans in different states.
Compare formulary status to other drugs in the same class.
Access your plan list on any device – mobile or desktop.

The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.

View explanations for tiers and restrictions

Tier	Description
1	This drug is available at the lowest co-pay. Most commonly, these are generic drugs.
2	This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.
3	This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.
4	This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
5	This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
6	This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
NC	NOT COVERED – Drugs that are not covered by the plan.

Code	Definition
PA	Prior Authorization Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
QL	Quantity Limits Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
ST	Step Therapy Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
OR	Other Restrictions Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.

Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.

[CLOSE WINDOW]